Humanized Mice in Translational Immunology

Translational Immunology: Mechanisms and Pharmacologic Approaches

Volumn , Issue , 2016, Pages 285-326

  Brehm, M A ^a   Bortell, R ^a   Verma, M ^b   Shultz, L D ^b   Greiner, D L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

BLT; Humanized mice; IL2rgnull; Immune response; Immunotherapy; NOD SCID IL2rgnull; NSG; SCID

Indexed keywords

EID: 84960837117     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-801577-3.00012-5     Document Type: Chapter

References (245)

1. Abraham S., Choi J.G., Ye C., Manjunath N., Shankar P. IL-10 exacerbates xenogeneic GVHD by inducing massive human T cell expansion. Clin. Immunol. 2015, 156:58-64.
2. Akkina R. Human immune responses and potential for vaccine assessment in humanized mice. Curr. Opin. Immunol. 2013, 25:403-409.
3. Akkina R. New generation humanized mice for virus research: comparative aspects and future prospects. Virology 2013, 435:14-28.
4. Andrade D., Redecha P.B., Vukelic M., Qing X., Perino G., Salmon J.E., Koo G.C. Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rgamma-/- mice: a promising model for studying human disease. Arthritis Rheum. 2011, 63:2764-2773.
5. Andre M.C., Erbacher A., Gille C., Schmauke V., Goecke B., Hohberger A., Mang P., Wilhelm A., Mueller I., Herr W., Lang P., Handgretinger R., Hartwig U.F. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells. J. Immunol. 2010, 185:2710-2720.
6. Antsiferova O., Muller A., Ramer P.C., Chijioke O., Chatterjee B., Raykova A., Planas R., Sospedra M., Shumilov A., Tsai M.H., Delecluse H.J., Munz C. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014, 10:e1004333.
7. Azuma H., Paulk N., Ranade A., Dorrell C., Al-Dhalimy M., Ellis E., Strom S., Kay M.A., Finegold M., Grompe M. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat. Biotechnol. 2007, 25:903-910.
8. Babad J., Mukherjee G., Follenzi A., Ali R., Roep B.O., Shultz L.D., Santamaria P., Yang O.O., Goldstein H., Greiner D.L., Dilorenzo T.P. Generation of beta cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient HLA-transgenic mice. Clin. Exp. Immunol. 2014, 131:459-465.
9. Balazs A.B., Chen J., Hong C.M., Rao D.S., Yang L., Baltimore D. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 2012, 481:81-84.
10. Baumler A., Fang F.C. Host specificity of bacterial pathogens. Cold Spring Harb. Perspect. Med. 2013, 3:a010041.
11. Beeching N.J., Fenech M., Houlihan C.F. Ebola virus disease. BMJ 2014, 349:g7348.
12. Bennett M.S., Akkina R. Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized mice. Viruses 2013, 5:3119-3141.
13. Bility M.T., Zhang L., Washburn M.L., Curtis T.A., Kovalev G.I., Su L. Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis. Nat. Protoc. 2012, 7:1608-1617.
14. Bility M.T., Li F., Cheng L., Su L. Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models. J. Gastroenterol. Hepatol. 2013, 28(Suppl. 1):120-124.
15. Billerbeck E., Barry W.T., Mu K., Dorner M., Rice C.M., Ploss A. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rgamma(null) humanized mice. Blood 2011, 117:3076-3086.
16. Billerbeck E., De J.Y., Dorner M., De La F.C., Ploss A. Animal models for hepatitis C. Curr. Top. Microbiol. Immunol. 2013, 369:49-86.
17. Biswas S., Chang H., Sarkis P.T., Fikrig E., Zhu Q., Marasco W.A. Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells. Immunology 2011, 134:419-433.
18. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009, 136:e28.
19. Brehm M.A., Shultz L.D. Human allograft rejection in humanized mice: a historical perspective. Cell. Mol. Immunol. 2012, 3:225-231.
20. Brehm M.A., Powers A.C., Shultz L.D., Greiner D.L. Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harb. Perspect. Med. 2012, 2:a007757.
21. Brehm M.A., Racki W.J., Leif J., Burzenski L., Hosur V., Wetmore A., Gott B., Herlihy M., Ignotz R., Dunn R., Shultz L.D., Greiner D.L. Engraftment of human HSC in non-irradiated newborn NOD-scid IL2rgammanull mice is enhanced by transgenic expression of membrane-bound human SCF. Blood 2012, 119:2778-2788.
22. Brehm M.A., Jouvet N., Greiner D.L., Shultz L.D. Humanized mice for the study of infectious diseases. Curr. Opin. Immunol. 2013, 25:428-435.
23. Brehm M.A., Wiles M.V., Greiner D.L., Shultz L.D. Generation of improved humanized mouse models for human infectious diseases. J. Immunol. Methods 2014, 410C:3-17.
24. Brentjens R.J., Riviere I., Park J.H., Davila M.L., Wang X., Stefanski J., Taylor C., Yeh R., Bartido S., Borquez-Ojeda O., Olszewska M., Bernal Y., Pegram H., Przybylowski M., Hollyman D., Usachenko Y., Pirraglia D., Hosey J., Santos E., Halton E., Maslak P., Scheinberg D., Jurcic J., Heaney M., Heller G., Frattini M., Sadelain M. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 2011, 118:4817-4828.
25. Brown D., Mattapallil J.J. Gastrointestinal tract and the mucosal macrophage reservoir in HIV infection. Clin. Vaccine Immunol. 2014, 21:1469-1473.
26. Bueno C., Montes R., De La C.T., Gutierrez-Aranda I., Menendez P. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation. Cytotherapy 2010, 12:45-49.
27. Burd E.M. Ebola virus: a clear and present danger. J. Clin. Microbiol. 2015, 53:4-8.
28. Calderon V.E., Valbuena G., Goez Y., Judy B.M., Huante M.B., Sutjita P., Johnston R.K., Estes D.M., Hunter R.L., Actor J.K., Cirillo J.D., Endsley J.J. A humanized mouse model of tuberculosis. PLoS One 2013, 8:e63331.
29. Cany J., Van Der Waart A.B., Tordoir M., Franssen G.M., Hangalapura B.N., De V.J., Boerman O., Schaap N., Van D.V., Spanholtz J., Dolstra H. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice. PLoS One 2013, 8:e64384.
30. Cao X., Kozak C.A., Liu Y.J., Noguchi M., O'connell E., Leonard W.J. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8464-8468.
31. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., Drago J., Noguchi M., Grinberg A., Bloom E.T., Paul W.E., Katz S.I., Love P.E., Leonard W.J. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
32. Carroll A.M., Bosma M.J. Detection and characterization of functional T cells in mice with severe combined immune deficiency. Eur. J. Immunol. 1988, 18:1965-1971.
33. Casucci M., Nicolis Di R.B., Falcone L., Camisa B., Norelli M., Genovese P., Gentner B., Gullotta F., Ponzoni M., Bernardi M., Marcatti M., Saudemont A., Bordignon C., Savoldo B., Ciceri F., Naldini L., Dotti G., Bonini C., Bondanza A. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Blood 2013, 122:3461-3472.
34. Casucci M., Hawkins R.E., Dotti G., Bondanza A. Overcoming the toxicity hurdles of genetically targeted T cells. Cancer Immunol. Immunother. 2015, 64:123-130.
35. Chao M.P., Alizadeh A.A., Tang C., Myklebust J.H., Varghese B., Gill S., Jan M., Cha A.C., Chan C.K., Tan B.T., Park C.Y., Zhao F., Kohrt H.E., Malumbres R., Briones J., Gascoyne R.D., Lossos I.S., Levy R., Weissman I.L., Majeti R. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 2010, 142:699-713.
36. Chao M.P., Weissman I.L., Majeti R. The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr. Opin. Immunol. 2012, 24:225-232.
37. Chateau M., Swanson M.D., Garcia J.V. Inefficient vaginal transmission of tenofovir-resistant HIV-1. J. Virol. 2013, 87:1274-1277.
38. Chateau M.L., Denton P.W., Swanson M.D., Mcgowan I., Garcia J.V. Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice. PLoS One 2013, 8:e60024.
39. Chatterjee B., Leung C.S., Munz C. Animal models of Epstein Barr virus infection. J. Immunol. Methods 2014, 410:80-87.
40. Chen Q., He F., Kwang J., Chan J.K., Chen J. GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J. Immunol. 2012, 189:5223-5229.
41. Chen Q., Amaladoss A., Ye W., Liu M., Dummler S., Kong F., Wong L.H., Loo H.L., Loh E., Tan S.Q., Tan T.C., Chang K.T., Dao M., Suresh S., Preiser P.R., Chen J. Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:1479-1484.
42. Cheung A.M., Leung D., Rostamirad S., Dhillon K., Miller P.H., Droumeva R., Brinkman R.R., Hogge D., Roy D.C., Eaves C.J. Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation. Blood 2012, 119:3431-3439.
43. Choi J.H., Jonsson-Schmunk K., Qiu X., Shedlock D.J., Strong J., Xu J.X., Michie K.L., Audet J., Fernando L., Myers M.J., Weiner D., Bajrovic I., Tran L.Q., Wong G., Bello A., Kobinger G.P., Schafer S.C., Croyle M.A. A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal ebola infection. Mol. Pharm 2015, 12:2712-2731.
44. Choo J.K., Seebach J.D., Nickeleit V., Shimizu A., Lei H., Sachs D.H., Madsen J.C. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 1997, 64:1315-1322.
45. Choudhary S.K., Archin N.M., Cheema M., Dahl N.P., Garcia J.V., Margolis D.M. Latent HIV-1 infection of resting CD4T cells in the humanized Rag2/gammac/mouse. J. Virol. 2012, 86:114-120.
46. Chowell G., Nishiura H. Transmission dynamics and control of Ebola virus disease (EVD): a review. BMC Med. 2014, 12:196.
47. Chu Y., Hochberg J., Yahr A., Ayello J., Van D.V., Barth M.J., Czuczman M.S., Cairo M.S. Targeting CD20+ aggressive B-cell non-hodgkin lymphoma by anti-CD20 CAR mRNA modified expanded natural killer cells in vitro and in NSG mice. Cancer Immunol. Res. 2015, 3:333-344. Epub, Dec. 9.
48. Cosgun K.N., Rahmig S., Mende N., Reinke S., Hauber I., Schafer C., Petzold A., Weisbach H., Heidkamp G., Purbojo A., Cesnjevar R., Platz A., Bornhauser M., Schmitz M., Dudziak D., Hauber J., Kirberg J., Waskow C. Kit regulates HSC engraftment across the human-mouse species barrier. Cell Stem Cell 2014, 15:227-238.
49. Coughlan A.M., Freeley S.J., Robson M.G. Humanised mice have functional human neutrophils. J. Immunol. Methods 2012, 385:96-104.
50. Covassin L., Laning J., Abdi R., Langevin D.L., Phillips N.E., Shultz L.D., Brehm M.A. Human peripheral blood CD4T cell-engrafted non-obese diabetic-scid IL2rgamma(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clin. Exp. Immunol. 2011, 166:269-280.
51. Covassin L., Jangalwe S., Jouvet N., Laning J., Burzenski L., Shultz L.D., Brehm M.A. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rgamma(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Clin. Exp. Immunol. 2013, 174:372-388.
52. Cox J., Mota J., Sukupolvi-Petty S., Diamond M.S., Rico-Hesse R. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J. Virol. 2012, 86:7637-7649.
53. Danner R., Chaudhari S.N., Rosenberger J., Surls J., Richie T.L., Brumeanu T.D., Casares S. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One 2011, 6:e19826.
54. Davis M.M. Immunology taught by humans. Sci. Transl. Med. 2012, 4:117fs2.
55. De W.E., Feldmann H., Munster V.J. Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies. Genome Med. 2011, 3:5.
56. Decker W.K., Shah N., Xing D., Lapushin R., Li S., Robinson S.N., Yang H., Parmar S., Halpert M.M., Keating M.J., Gribben J.G., Molldrem J.J., Shpall E.J., Wierda W.G. Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC. PLoS One 2012, 7:e51390.
57. Deng K., Pertea M., Rongvaux A., Wang L., Durand C.M., Ghiaur G., Lai J., Mchugh H.L., Hao H., Zhang H., Margolick J.B., Gurer C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Deeks S.G., Strowig T., Kumar P., Siliciano J.D., Salzberg S.L., Flavell R.A., Shan L., Siliciano R.F. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 2015, 517:381-385.
58. Denton P.W., Garcia J.V. Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol. 2012, 20:268-274.
59. Denton P.W., Olesen R., Choudhary S.K., Archin N.M., Wahl A., Swanson M.D., Chateau M., Nochi T., Krisko J.F., Spagnuolo R.A., Margolis D.M., Garcia J.V. Generation of HIV latency in humanized BLT mice. J. Virol. 2012, 86:630-634.
60. Deruaz M., Luster A.D. BLT humanized mice as model to study HIV vaginal transmission. J. Infect. Dis. 2013, 208(Suppl. 2):S131-S136.
61. Didigu C.A., Wilen C.B., Wang J., Duong J., Secreto A.J., Net-Desnoyers G.A., Riley J.L., Gregory P.D., June C.H., Holmes M.C., Doms R.W. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood 2013, 123:61-69.
62. Ding Y., Wilkinson A., Idris A., Fancke B., O'keeffe M., Khalil D., Ju X., Lahoud M.H., Caminschi I., Shortman K., Rodwell R., Vuckovic S., Radford K.J. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+dendritic cells in vivo. J. Immunol. 2014, 192:1982-1989.
63. Distler E., Wolfel C., Kohler S., Nonn M., Kaus N., Schnurer E., Meyer R.G., Wehler T.C., Huber C., Wolfel T., Hartwig U.F., Herr W. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice. Exp. Hematol. 2008, 36:451-463.
64. Doeing D.C., Borowicz J.L., Crockett E.T. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin. Pathol. 2003, 3:3.
65. Ernst W., Zimara N., Hanses F., Mannel D.N., Seelbach-Gobel B., Wege A.K. Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect. Immun. 2013, 81:1520-1531.
66. Fellner C. Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use. Proc. Natl. Acad. Sci. U. S. A. 2012, 37:503-530.
67. Fisher T.S., Kamperschroer C., Oliphant T., Love V.A., Lira P.D., Doyonnas R., Bergqvist S., Baxi S.M., Rohner A., Shen A.C., Huang C., Sokolowski S.A., Sharp L.L. Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity. Cancer Immunol. Immunother. 2012, 61:1721-1733.
68. Fujiwara S. Reproduction of epstein-barr virus infection and pathogenesis in humanized mice. Immune Netw. 2014, 14:1-6.
69. Fujiwara S., Matsuda G., Imadome K. Humanized mouse models of epstein-barr virus infection and associated diseases. Pathogens 2013, 2:153-176.
70. Gill S., June C.H. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunol. Rev. 2015, 263:68-89.
71. Gille C., Orlikowsky T.W., Spring B., Hartwig U.F., Wilhelm A., Wirth A., Goecke B., Handgretinger R., Poets C.F., Andre M.C. Monocytes derived from humanized neonatal NOD/SCID/IL2Rgamma(null) mice are phenotypically immature and exhibit functional impairments. Hum. Immunol. 2012, 73:346-354.
72. Gonzalez L., Strbo N., Podack E.R. Humanized mice: novel model for studying mechanisms of human immune-based therapies. Immunol. Res. 2013, 57:326-334.
73. Greenbaum C.J., Schatz D.A., Haller M.J., Sanda S. Through the fog: recent clinical trials to preserve beta-cell function in type 1 diabetes. Diabetes 2012, 61:1323-1330.
74. Greenblatt M.B., Vbranac V., Tivey T., Tsang K., Tager A.M., Aliprantis A.O. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One 2012, 7:e44664.
75. Gregoire-Gauthier J., Selleri S., Fontaine F., Dieng M.M., Patey N., Despars G., Beausejour C.M., Haddad E. Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model. Stem Cells Dev. 2012, 21:1616-1626.
76. Grompe M., Strom S. Mice with human livers. Gastroenterology 2013, 145:1209-1214.
77. Guedan S., Chen X., Madar A., Carpenito C., Mcgettigan S.E., Frigault M.J., Lee J., Posey A.D., Scholler J., Scholler N., Bonneau R., June C.H. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood 2014, 124:1070-1080.
78. Gutti T.L., Knibbe J.S., Makarov E., Zhang J., Yannam G.R., Gorantla S., Sun Y., Mercer D.F., Suemizu H., Wisecarver J.L., Osna N.A., Bronich T.K., Poluektova L.Y. Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice. Am. J. Pathol. 2014, 184:101-109.
79. Hamid O., Robert C., Daud A., Hodi F.S., Hwu W.J., Kefford R., Wolchok J.D., Hersey P., Joseph R.W., Weber J.S., Dronca R., Gangadhar T.C., Patnaik A., Zarour H., Joshua A.M., Gergich K., Elassaiss-Schaap J., Algazi A., Mateus C., Boasberg P., Tumeh P.C., Chmielowski B., Ebbinghaus S.W., Li X.N., Kang S.P., Ribas A. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 2013, 369:134-144.
80. Harui A., Kiertscher S.M., Roth M.D. Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation. J. Neuroimmune Pharmacol. 2011, 6:148-157.
81. Hasegawa M., Kawai K., Mitsui T., Taniguchi K., Monnai M., Wakui M., Ito M., Suematsu M., Peltz G., Nakamura M., Suemizu H. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem. Biophys. Res. Commun. 2011, 405:405-410.
82. Hayakawa J., Hsieh M.M., Uchida N., Phang O., Tisdale J.F. Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice. Stem Cells 2009, 27:175-182.
83. Heuts F., Gavier-Widen D., Carow B., Juarez J., Wigzell H., Rottenberg M.E. CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:6482-6487.
84. Hodi F.S., O'day S.J., Mcdermott D.F., Weber R.W., Sosman J.A., Haanen J.B., Gonzalez R., Robert C., Schadendorf D., Hassel J.C., Akerley W., Van Den Eertwegh A.J., Lutzky J., Lorigan P., Vaubel J.M., Linette G.P., Hogg D., Ottensmeier C.H., Lebbe C., Peschel C., Quirt I., Clark J.I., Wolchok J.D., Weber J.S., Tian J., Yellin M.J., Nichol G.M., Hoos A., Urba W.J. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 2010, 363:711-723.
85. Hofer U., Henley J.E., Exline C.M., Mulhern O., Lopez E., Cannon P.M. Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice. J. Infect. Dis. 2013, 208(Suppl. 2):S160-S164.
86. Honeycutt J.B., Wahl A., Archin N., Choudhary S., Margolis D., Garcia J.V. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model. Retrovirology 2013, 10:121.
87. Hu Z., Yang Y.G. Full reconstitution of human platelets in humanized mice after macrophage depletion. Blood 2012, 120:1713-1716.
88. Hu Z., Van R.N., Yang Y.G. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood 2011, 118:5938-5946.
89. Huang J., Li X., Coelho-Dos-Reis J.G., Wilson J.M., Tsuji M. An AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in mice. PLoS One 2014, 9:e88205.
90. Hudecek M., Lupo-Stanghellini M.T., Kosasih P.L., Sommermeyer D., Jensen M.C., Rader C., Riddell S.R. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells. Clin. Cancer Res. 2013, 19:3153-3164.
91. Huntington N.D., Legrand N., Alves N.L., Jaron B., Weijer K., Plet A., Corcuff E., Mortier E., Jacques Y., Spits H., Di Santo J.P. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 2009, 206:25-34.
92. Huntington N.D., Alves N.L., Legrand N., Lim A., Strick-Marchand H., Mention J.J., Plet A., Weijer K., Jacques Y., Becker P.D., Guzman C., Soussan P., Kremsdorf D., Spits H., Di Santo J.P. IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6217-6222.
93. Hur E.M., Patel S.N., Shimizu S., Rao D.S., Gnanapragasam P.N., An D.S., Yang L., Baltimore D. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 2012, 120:4571-4582.
94. Ippolito G.C., Hoi K.H., Reddy S.T., Carroll S.M., Ge X., Rogosch T., Zemlin M., Shultz L.D., Ellington A.D., Vandenberg C.L., Georgiou G. Antibody repertoires in humanized NOD-scid-IL2Rgamma(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS One 2012, 7:e35497.
95. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., Ueyama Y., Koyanagi Y., Sugamura K., Tsuji K., Heike T., Nakahata T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182.
96. Ito R., Katano I., Kawai K., Hirata H., Ogura T., Kamisako T., Eto T., Ito M. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 2009, 87:1654-1658.
97. Ito R., Takahashi T., Katano I., Ito M. Current advances in humanized mouse models. Cell. Mol. Immunol. 2012, 9:208-214.
98. Ito R., Takahashi T., Katano I., Kawai K., Kamisako T., Ogura T., Ida-Tanaka M., Suemizu H., Nunomura S., Ra C., Mori A., Aiso S., Ito M. Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. J. Immunol. 2013, 191:2890-2899.
99. Iwamoto C., Takenaka K., Urata S., Yamauchi T., Shima T., Kuriyama T., Daitoku S., Saito Y., Miyamoto T., Iwasaki H., Kitabayashi I., Itoh K., Kishimoto J., Kohda D., Matozaki T., Akashi K. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment. Exp. Hematol. 2014, 42:163-171.
100. Jaiswal S., Pearson T., Friberg H., Shultz L.D., Greiner D.L., Rothman A.L., Mathew A. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One 2009, 4:e7251.
101. Jaiswal S., Pazoles P., Woda M., Shultz L.D., Greiner D.L., Brehm M.A., Mathew A. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology 2012, 136:334-343.
102. Jaiswal S., Smith K., Ramirez A., Woda M., Pazoles P., Shultz L.D., Greiner D.L., Brehm M.A., Mathew A. Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice. Exp. Biol. Med. (Maywood) 2015, 240:67-78.
103. Jang Y.K., Kim M., Lee Y.H., Oh W., Yang Y.S., Choi S.J. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease. Cytotherapy 2014, 16:298-308.
104. Jimenez-Diaz M.B., Mulet T., Viera S., Gomez V., Garuti H., Ibanez J., Varez-Doval A., Shultz L.D., Martinez A., Gargallo-Viola D., Ngulo-Barturen I. Improved murine model of malaria using plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrob. Agents Chemother. 2009, 53:4533-4536.
105. Kaehler K.C., Piel S., Livingstone E., Schilling B., Hauschild A., Schadendorf D. Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management. Semin. Oncol. 2010, 37:485-498.
106. Kamel-Reid S., Dick J.E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988, 242:1706-1709.
107. Kaushansky A., Mikolajczak S.A., Vignali M., Kappe S.H. Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections. Cell. Microbiol. 2014, 16:602-611.
108. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
109. Kerekov N.S., Mihaylova N.M., Grozdev I., Todorov T.A., Nikolova M., Baleva M., Nikolova M., Prechl J., Erdei A., Tchorbanov A.I. Elimination of autoreactive B cells in humanized SCID mouse model of SLE. Eur. J. Immunol. 2011, 41:3301-3311.
110. King M.A., Covassin L., Brehm M.A., Racki W., Pearson T., Leif J., Laning J., Fodor W., Foreman O., Burzenski L., Chase T., Gott B., Rossini A.A., Bortell R., Shultz L.D., Greiner D.L. Hu-PBL-NOD- scid IL2rg null mouse model of xenogeneic graft-versus-host-like disease and the role of host MHC. Clin. Exp. Immunol. 2009, 157:104-118.
111. Kloss C.C., Condomines M., Cartellieri M., Bachmann M., Sadelain M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nat. Biotechnol. 2013, 31:71-75.
112. Kochenderfer J.N., Dudley M.E., Feldman S.A., Wilson W.H., Spaner D.E., Maric I., Stetler-Stevenson M., Phan G.Q., Hughes M.S., Sherry R.M., Yang J.C., Kammula U.S., Devillier L., Carpenter R., Nathan D.A., Morgan R.A., Laurencot C., Rosenberg S.A. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 2012, 119:2709-2720.
113. Koreth J., Matsuoka K., Kim H.T., Mcdonough S.M., Bindra B., Alyea E.P., Armand P., Cutler C., Ho V.T., Treister N.S., Bienfang D.C., Prasad S., Tzachanis D., Joyce R.M., Avigan D.E., Antin J.H., Ritz J., Soiffer R.J. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 2011, 365:2055-2066.
114. Kumar A., Abbas W., Herbein G. HIV-1 latency in monocytes/macrophages. Viruses 2014, 6:1837-1860.
115. Kuwana Y., Takei M., Yajima M., Imadome K., Inomata H., Shiozaki M., Ikumi N., Nozaki T., Shiraiwa H., Kitamura N., Takeuchi J., Sawada S., Yamamoto N., Shimizu N., Ito M., Fujiwara S. Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS One 2011, 6:e26630.
116. Lan P., Tonomura N., Shimizu A., Wang S., Yang Y.G. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 2006, 108:487-492.
117. Langlois M., Delanghe J., Philippe J., Ouyang J., Bernard D., De Buyzere M., Van Nooten G., Leroux-Roels G. Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD22. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35:199-205.
118. Lavender K.J., Pang W.W., Messer R.J., Duley A.K., Race B., Phillips K., Scott D., Peterson K.E., Chan C.K., Dittmer U., Dudek T., Allen T.M., Weissman I.L., Hasenkrug K.J. BLT-humanized C57BL/6 Rag2-/-gammac-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood 2013, 122:4013-4020.
119. Lavender K.J., Messer R.J., Race B., Hasenkrug K.J. Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2(-/-)gammac(-/-)CD47(-/-) background. J. Immunol. Methods 2014, 407:127-134.
120. Lee J., Brehm M.A., Greiner D., Shultz L.D., Kornfeld H. Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice. BMC Immunol. 2013, 14:53.
121. Lepus C.M., Gibson T.F., Gerber S.A., Kawikova I., Szczepanik M., Hossain J., Ablamunits V., Kirkiles-Smith N., Herold K.C., Donis R.O., Bothwell A.L., Pober J.S., Harding M.J. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. Hum. Immunol. 2009, 70:790-802.
122. Leung C., Chijioke O., Gujer C., Chatterjee B., Antsiferova O., Landtwing V., Mchugh D., Raykova A., Munz C. Infectious diseases in humanized mice. Eur. J. Immunol. 2013, 43:2246-2254.
123. Li Y., Chen Q., Zheng D., Yin L., Chionh Y.H., Wong L.H., Tan S.Q., Tan T.C., Chan J.K., Alonso S., Dedon P.C., Lim B., Chen J. Induction of functional human macrophages from bone marrow promonocytes by M-CSF in humanized mice. J. Immunol. 2013, 191:3192-3199.
124. Libby S.J., Brehm M.A., Greiner D.L., Shultz L.D., Mcclelland M., Smith K.D., Cookson B.T., Karlinsey J.E., Kinkel T.L., Porwollik S., Canals R., Cummings L.A., Fang F.C. Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15589-15594.
125. Little M.A., Al-Ani B., Ren S., Al-Nuaimi H., Leite M., Alpers C.E., Savage C.O., Duffield J.S. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One 2012, 7:e28626.
126. Lockridge J.L., Zhou Y., Becker Y.A., Ma S., Kenney S.C., Hematti P., Capitini C.M., Burlingham W.J., Gendron-Fitzpatrick A., Gumperz J.E. Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 2013, 19:1310-1322.
127. Ma S.D., Yu X., Mertz J.E., Gumperz J.E., Reinheim E., Zhou Y., Tang W., Burlingham W.J., Gulley M.L., Kenney S.C. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J. Virol. 2012, 86:7976-7987.
128. Ma S.-D., Xu X., Plowshay J., Ranheim E.A., Burlingham W.J., Jensen J.L., Asimakopoulos F., Tang W., Gulley M.L., Cesarman E., Gumperz J.E., Kenney S.C. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. J. Clin. Invest. 2015, 125:304-315.
129. Markley J.C., Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood 2010, 115:3508-3519.
130. Marsden M.D., Kovochich M., Suree N., Shimizu S., Mehta R., Cortado R., Bristol G., An D.S., Zack J.A. HIV latency in the humanized BLT mouse. J. Virol. 2012, 86:339-347.
131. Martin H., Reuter S., Dehzad N., Heinz A., Bellinghausen I., Saloga J., Haasler I., Korn S., Jonuleit H., Buhl R., Becker C., Taube C. CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease. J. Allergy Clin. Immunol. 2012, 129(521-8):528.
132. Marzi A., Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert Rev. Vaccines 2014, 13:521-531.
133. Matsuoka K., Koreth J., Kim H.T., Bascug G., Mcdonough S., Kawano Y., Murase K., Cutler C., Ho V.T., Alyea E.P., Armand P., Blazar B.R., Antin J.H., Soiffer R.J., Ritz J. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci. Transl. Med. 2013, 5:179ra43.
134. Maus M.V., Haas A.R., Beatty G.L., Albelda S.M., Levine B.L., Liu X., Zhao Y., Kalos M., June C.H. T cells expressing chimeric antigen receptors can cause anaphylaxis in humans. Cancer Immunol. Res. 2013, 1:26-31.
135. Mccune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
136. Mcdermott S.P., Eppert K., Lechman E.R., Doedens M., Dick J.E. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 2010, 116:193-200.
137. Mcneer N.A., Schleifman E.B., Cuthbert A., Brehm M., Jackson A., Cheng C., Anandalingam K., Kumar P., Shultz L.D., Greiner D.L., Mark S.W., Glazer P.M. Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther. 2012, 20:658-659.
138. Meixlsperger S., Leung C.S., Ramer P.C., Pack M., Vanoaica L.D., Breton G., Pascolo S., Salazar A.M., Dzionek A., Schmitz J., Steinman R.M., Munz C. CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood 2013, 121:5034-5044.
139. Melero I., Hervas-Stubbs S., Glennie M., Pardoll D.M., Chen L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 2007, 7:95-106.
140. Melkus M.W., Estes J.D., Padgett-Thomas A., Gatlin J., Denton P.W., Othieno F.A., Wege A.K., Haase A.T., Garcia J.V. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006, 12:1316-1322.
141. Mercer D.F., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., Addison W.R., Fischer K.P., Churchill T.A., Lakey J.R., Tyrrell D.L., Kneteman N.M. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 2001, 7:927-933.
142. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004, 172:2731-2738.
143. Miller P.H., Cheung A.M., Beer P.A., Knapp D.J., Dhillon K., Rabu G., Rostamirad S., Humphries R.K., Eaves C.J. Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors. Blood 2013, 121:e1-e4.
144. Milone M.C., Fish J.D., Carpenito C., Carroll R.G., Binder G.K., Teachey D., Samanta M., Lakhal M., Gloss B., Net-Desnoyers G., Campana D., Riley J.L., Grupp S.A., June C.H. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 2009, 17:1453-1464.
145. Misharin A.V., Haines G.K., Rose S., Gierut A.K., Hotchkiss R.S., Perlman H. Development of a new humanized mouse model to study acute inflammatory arthritis. J. Transl. Med. 2012, 10:190.
146. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., Royal R.E., Topalian S.L., Kammula U.S., Restifo N.P., Zheng Z., Nahvi A., De Vries C.R., Rogers-Freezer L.J., Mavroukakis S.A., Rosenberg S.A. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314:126-129.
147. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335:256-259.
148. Mota J., Rico-Hesse R. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J. Virol. 2009, 83:8638-8645.
149. Mueller S.N., Gebhardt T., Carbone F.R., Heath W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 2013, 31:137-161.
150. Mullard A. New checkpoint inhibitors ride the immunotherapy tsunami. Nat. Rev. Drug Discov. 2013, 12:489-492.
151. Munz C. Viral infections in mice with reconstituted human immune system components. Immunol. Lett. 2014, 161:118-124.
152. Neff C.P., Zhou J., Remling L., Kuruvilla J., Zhang J., Li H., Smith D.D., Swiderski P., Rossi J.J., Akkina R. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice. Sci. Transl. Med. 2011, 3:66ra6.
153. Nestle F.O., Di M.P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 2009, 9:679-691.
154. Nischang M., Sutmuller R., Gers-Huber G., Audige A., Li D., Rochat M.A., Baenziger S., Hofer U., Schlaepfer E., Regenass S., Amssoms K., Stoops B., Van C.A., Boden D., Kraus G., Speck R.F. Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1. PLoS One 2012, 7:e38853.
155. Nolte T., Zadeh-Khorasani M., Safarov O., Rueff F., Gulberg V., Herbach N., Wollenberg A., Mueller T., Siebeck M., Wolf E., Gropp R. Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rgamma(null) mice engrafted with human peripheral blood mononuclear cells. Clin. Exp. Immunol. 2013, 172:349-362.
156. Nolte T., Zadeh-Khorasani M., Safarov O., Rueff F., Varga R., Herbach N., Wanke R., Wollenberg A., Mueller T., Gropp R., Wolf E., Siebeck M. Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rgamma(null) mice engrafted with human peripheral blood mononuclear cells. Dis. Model. Mech. 2013, 6:125-134.
157. Ohaegbulam K.C., Assal A., Lazar-Molnar E., Yao Y., Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol. Med. 2015, 21:24-33.
158. Onoe T., Kalscheuer H., Danzl N., Chittenden M., Zhao G., Yang Y.G., Sykes M. Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model. J. Immunol. 2011, 187:3895-3903.
159. Palucka K., Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 2013, 39:38-48.
160. Pawluczkowycz A.W., Beurskens F.J., Beum P.V., Lindorfer M.A., Van De Winkel J.G., Parren P.W., Taylor R.P. Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX. J. Immunol. 2009, 183:749-758.
161. Pearson T., Greiner D.L., Shultz L.D. Creation of "humanized" mice to study human immunity. Curr. Protoc. Immunol. 2008, Supplement 81, Chapter 15, Unit-15.21. 10.1002/0471142735.im1521s81.
162. Pham H.P., Manuel M., Petit N., Klatzmann D., Cohen-Kaminsky S., Six A., Marodon G. Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice. Eur. J. Immunol. 2012, 42:760-770.
163. Porter D.L., Levine B.L., Kalos M., Bagg A., June C.H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 2011, 365:725-733.
164. Putnam A.L., Safinia N., Medvec A., Laszkowska M., Wray M., Mintz M.A., Trotta E., Szot G.L., Liu W., Lares A., Lee K., Laing A., Lechler R.I., Riley J.L., Bluestone J.A., Lombardi G., Tang Q. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am. J. Transplant. 2013, 13:3010-3020.
165. Racki W.J., Covassin L., Brehm M., Pino S., Ignotz R., Dunn R., Laning J., Rossini A.A., Shultz L.D., Greiner D.L. NOD- scid IL2rg null (NSG) mouse model of human skin transplantation and allograft rejection. Transplantation 2010, 89:527-536.
166. Ranganathan P., Yu X., Na C., Santhanam R., Shacham S., Kauffman M., Walker A., Klisovic R., Blum W., Caligiuri M., Croce C.M., Marcucci G., Garzon R. Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood 2012, 120:1765-1773.
167. Rasmussen A.L., Okumura A., Ferris M.T., Green R., Feldmann F., Kelly S.M., Scott D.P., Safronetz D., Haddock E., Lacasse R., Thomas M.J., Sova P., Carter V.S., Weiss J.M., Miller D.R., Shaw G.D., Korth M.J., Heise M.T., Baric R.S., De Villena F.P., Feldmann H., Katze M.G. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 2014, 346:987-991.
168. Rhim J.A., Sandgren E.P., Degen J.L., Palmiter R.D., Brinster R.L. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994, 263:1149-1152.
169. Rongvaux A., Willinger T., Takizawa H., Rathinam C., Auerbach W., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Eynon E.E., Stevens S., Manz M.G., Flavell R.A. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2378-2383.
170. Rongvaux A., Takizawa H., Strowig T., Willinger T., Eynon E.E., Flavell R.A., Manz M.G. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu. Rev. Immunol. 2013, 31:635-674.
171. Rongvaux A., Willinger T., Martinek J., Strowig T., Gearty S.V., Teichmann L.L., Saito Y., Marches F., Halene S., Palucka A.K., Manz M.G., Flavell R.A. Development and function of human innate immune cells in a humanized mouse model. Nat. Biotechnol. 2014, 32:364-372.
172. Rygaard J., Povlsen C.O. Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol. Microbiol. Scand. 1969, 77:758-760.
173. Saadoun D., Rosenzwajg M., Joly F., Six A., Carrat F., Thibault V., Sene D., Cacoub P., Klatzmann D. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 2011, 365:2067-2077.
174. Savoldo B., Ramos C.A., Liu E., Mims M.P., Keating M.J., Carrum G., Kamble R.T., Bollard C.M., Gee A.P., Mei Z., Liu H., Grilley B., Rooney C.M., Heslop H.E., Brenner M.K., Dotti G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J. Clin. Invest. 2011, 121:1822-1826.
175. Schleifman E.B., Bindra R., Leif J., Del C.J., Rogers F.A., Uchil P., Kutsch O., Shultz L.D., Kumar P., Greiner D.L., Glazer P.M. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem. Biol. 2011, 18:1189-1198.
176. Schleifman E.B., Mcneer N.A., Jackson A., Yamtich J., Brehm M.A., Shultz L.D., Greiner D.L., Kumar P., Saltzman W.M., Glazer P.M. Site-specific genome editing in PBMCs with PLGA nanoparticle-delivered PNAs confers HIV-1 resistance in humanized mice. Mol. Ther. Nucleic Acids. 2013, 2:e135.
177. Schmidt M.R., Appel M.C., Giassi L.J., Greiner D.L., Shultz L.D., Woodland R.T. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One 2008, 3:e3192.
178. Scott S.D. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. Cancer Pract. 1998, 6:195-197.
179. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Xu W., Richards D.R., Donald-Smith G.P., Gao H., Hennessy L., Finnerty C.C., Lopez C.M., Honari S., Moore E.E., Minei J.P., Cuschieri J., Bankey P.E., Johnson J.L., Sperry J., Nathens A.B., Billiar T.R., West M.A., Jeschke M.G., Klein M.B., Gamelli R.L., Gibran N.S., Brownstein B.H., Miller-Graziano C., Calvano S.E., Mason P.H., Cobb J.P., Rahme L.G., Lowry S.F., Maier R.V., Moldawer L.L., Herndon D.N., Davis R.W., Xiao W., Tompkins R.G. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3507-3512.
180. Shih C.C., Hu J., Arber D., Lebon T., Forman S.J. Transplantation and growth characteristics of human fetal lymph node in immunodeficient mice. Exp. Hematol. 2000, 28:1046-1053.
181. Shiokawa M., Takahashi T., Murakami A., Kita S., Ito M., Sugamura K., Ishii N. In vivo assay of human NK-dependent ADCC using NOD/SCID/gammac(null) (NOG) mice. Biochem. Biophys. Res. Commun. 2010, 399:733-737.
182. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer I.B., Mckenna S., Mobraaten L., Rajan T.V., Greiner D.L., Leiter E.H. Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice. J. Immunol. 1995, 154:180-191.
183. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., Gillies S.D., King M., Mangada J., Greiner D.L., Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz- scid IL2r g null mice engrafted with mobilized human hematopoietic stem cell. J. Immunol. 2005, 174:6477-6489.
184. Shultz L.D., Ishikawa F., Greiner D.L. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 2007, 7:118-130.
185. Shultz L.D., Saito Y., Najima Y., Tanaka S., Ochi T., Tomizawa M., Doi T., Sone A., Suzuki N., Fujiwara H., Yasukawa M., Ishikawa F. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13022-13027.
186. Shultz L.D., Brehm M.A., Garcia-Martinez J.V., Greiner D.L. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 2012, 12:786-798.
187. Shultz L.D., Goodwin N., Ishikawa F., Hosur V., Lyons B.L., Greiner D.L. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb. Protoc. 2014, 2014:694-708.
188. Siliciano J.D., Siliciano R.F. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1. J. Allergy Clin. Immunol. 2014, 134:12-19.
189. Sliva K. Latest animal models for anti-HIV drug discovery. Expert. Opin. Drug Discov. 2014, 10:111-123.
190. Sonar S.S., Hsu Y.M., Conrad M.L., Majeau G.R., Kilic A., Garber E., Gao Y., Nwankwo C., Willer G., Dudda J.C., Kim H., Bailly V., Pagenstecher A., Rennert P.D., Renz H. Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J. Clin. Invest. 2010, 120:2767-2781.
191. Song J., Willinger T., Rongvaux A., Eynon E.E., Stevens S., Manz M.G., Flavell R.A., Galan J.E. A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe 2010, 8:369-376.
192. Song D.G., Ye Q., Carpenito C., Poussin M., Wang L.P., Ji C., Figini M., June C.H., Coukos G., Powell D.J. In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). Cancer Res. 2011, 71:4617-4627.
193. Song D.G., Ye Q., Poussin M., Harms G.M., Figini M., Powell D.J. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood 2012, 119:696-706.
194. Soria A., Boccara D., Chonco L., Yahia N., Dufossee M., Cardinaud S., Moris A., Liard C., Joulin-Giet A., Julithe M., Mimoun M., Combadiere B., Perrin H. Long-term maintenance of skin immune system in a NOD-Scid IL2rgamma(null) mouse model transplanted with human skin. Exp. Dermatol. 2014, 23:850-852.
195. Spranger S., Frankenberger B., Schendel D.J. NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo. J. Transl. Med. 2012, 10:30.
196. Stoddart C.A., Maidji E., Galkina S.A., Kosikova G., Rivera J.M., Moreno M.E., Sloan B., Joshi P., Long B.R. Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rgamma(-/-) (NSG) BLT mice. Virology 2011, 417:154-160.
197. Stoddart C.A., Nault G., Galkina S.A., Bousquet-Gagnon N., Bridon D., Quraishi O. Preexposure prophylaxis with albumin-conjugated C34 peptide HIV-1 fusion inhibitor in SCID-hu Thy/Liv mice. Antimicrob. Agents Chemother. 2012, 56:2162-2165.
198. Strowig T., Gurer C., Ploss A., Liu Y.F., Arrey F., Sashihara J., Koo G., Rice C.M., Young J.W., Chadburn A., Cohen J.I., Munz C. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 2009, 206:1423-1434.
199. Strowig T., Chijioke O., Carrega P., Arrey F., Meixlsperger S., Ramer P.C., Ferlazzo G., Munz C. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 2010, 116:4158-4167.
200. Strowig T., Rongvaux A., Rathinam C., Takizawa H., Borsotti C., Philbrick W., Eynon E.E., Manz M.G., Flavell R.A. Transgenic expression of human signal regulatory protein alpha in Rag2-/-[gamma]c-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13218-13223.
201. Suzuki M., Takahashi T., Katano I., Ito R., Ito M., Harigae H., Ishii N., Sugamura K. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/gammacnull mouse. Int. Immunol. 2012, 24:243-252.
202. Takagi S., Saito Y., Hijikata A., Tanaka S., Watanabe T., Hasegawa T., Mochizuki S., Kunisawa J., Kiyono H., Koseki H., Ohara O., Saito T., Taniguchi S., Shultz L.D., Ishikawa F. Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 2012, 119:2768-2777.
203. Takao K., Miyakawa T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:1167-1172. Epub, Aug. 4.
204. Takao K., Hagihara H., Miyakawa T. Reply to Warren et al. and Shay et al.: commonalities across species do exist and are potentially important. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:E347-E348. Epub, Dec 24.
205. Tanaka S., Saito Y., Kunisawa J., Kurashima Y., Wake T., Suzuki N., Shultz L.D., Kiyono H., Ishikawa F. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rgammaKO mice. J. Immunol. 2012, 188:6145-6155.
206. Tang Q., Bluestone J.A. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb. Perspect. Med. 2013, 3:1-15.
207. Taube R., Peterlin M. Lost in transcription: molecular mechanisms that control HIV latency. Viruses 2013, 5:902-927.
208. Todd J., Knip M., Mathieu C. Towards disease mechanism-based strategies for the prevention of autoimmune Type 1 diabetes. Diabet. Med. 2011, 28:1141-1143.
209. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J.C., Lanzavecchia A., Manz M.G. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104-107.
210. Tseng C., Chan Y. Overview of Ebola virus disease in 2014. J. Chin. Med. Assoc. 2015, 78:51-55.
211. Tumeh P.C., Harview C.L., Yearley J.H., Shintaku I.P., Taylor E.J., Robert L., Chmielowski B., Spasic M., Henry G., Ciobanu V., West A.N., Carmona M., Kivork C., Seja E., Cherry G., Gutierrez A.J., Grogan T.R., Mateus C., Tomasic G., Glaspy J.A., Emerson R.O., Robins H., Pierce R.H., Elashoff D.A., Robert C., Ribas A. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014, 515:568-571.
212. Unger W.W., Pearson T., Abreu J.R., Laban S., Van Der Slik A.R., Der Kracht S.M., Kester M.G., Serreze D.V., Shultz L.D., Griffioen M., Drijfhout J.W., Greiner D.L., Roep B.O. Islet-specific CTL Cloned from a Type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 Transgenic NOD/SCID/IL2RG Null Mice. PLoS One 2012, 7:e49213.
213. Unsinger J., Mcdonough J.S., Shultz L.D., Ferguson T.A., Hotchkiss R.S. Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice. J. Leukoc. Biol. 2009, 86:219-227.
214. Vallet V., Mauray S., Kindler V., Aubry D., Ruegg M., Cherpillod J., Waridel F., Schapira M., Duchosal M.A. Human tonsil implants xenotransplanted in SCID mice display broad lymphocytic diversity and cellular activation profile similar to those in the original lymphoid organ. Xenotransplantation 2005, 12:38-48.
215. Vaughan A.M., Mikolajczak S.A., Wilson E.M., Grompe M., Kaushansky A., Camargo N., Bial J., Ploss A., Kappe S.H. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J. Clin. Invest. 2012, 122:3618-3628.
216. Viehmann Milam A.A., Maher S.E., Gibson J.A., Lebastchi J., Wen L., Ruddle N.H., Herold K.C., Bothwell A.L. A humanized mouse model of autoimmune insulitis. Diabetes 2014, 63:1712-1724.
217. Villaudy J., Schotte R., Legrand N., Spits H. Critical assessment of human antibody generation in humanized mouse models. J. Immunol. Methods 2014, 410C:18-27.
218. Von S.M., Ding Q., Ploss A. Visualizing hepatitis C virus infection in humanized mice. J. Immunol. Methods 2014, 410:50-59.
219. Vudattu N.K., Waldron-Lynch F., Truman L.A., Deng S., Preston-Hurlburt P., Torres R., Raycroft M.T., Mamula M.J., Herold K.C. Humanized mice as a model for aberrant responses in human T cell immunotherapy. J. Immunol. 2014, 193:587-596.
220. Vuyyuru R., Patton J., Manser T. Human immune system mice: current potential and limitations for translational research on human antibody responses. Immunol. Res. 2011, 51:257-266.
221. Wahl A., Swanson M.D., Nochi T., Olesen R., Denton P.W., Chateau M., Garcia J.V. Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathog. 2012, 8:e1002732.
222. Warren H.S., Tompkins R.G., Moldawer L.L., Seok J., Xu W., Mindrinos M.N., Maier R.V., Xiao W., Davis R.W. Mice are not men. Proc. Natl. Acad. Sci. U.S.A 2014, 12. E345, Epub, Dec. 24.
223. Warren T.K., Wells J., Panchal R.G., Stuthman K.S., Garza N.L., Van Tongeren S.A., Dong L., Retterer C.J., Eaton B.P., Pegoraro G., Honnold S., Bantia S., Kotian P., Chen X., Taubenheim B.R., Welch L.S., Minning D.M., Babu Y.S., Sheridan W.P., Bavari S. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014, 508:402-405.
224. Washburn M.L., Bility M.T., Zhang L., Kovalev G.I., Buntzman A., Frelinger J.A., Barry W., Ploss A., Rice C.M., Su L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011, 140:1334-1344.
225. Watanabe Y., Takahashi T., Okajima A., Shiokawa M., Ishii N., Katano I., Ito R., Ito M., Minegishi M., Minegishi N., Tsuchiya S., Sugamura K. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int. Immunol. 2009, 21:843-858.
226. Weber J. Immune checkpoint proteins: a new therapeutic paradigm for cancer-preclinical background: CTLA-4 and PD-1 blockade. Semin. Oncol. 2010, 37:430-439.
227. Wege A.K., Ernst W., Eckl J., Frankenberger B., Vollmann-Zwerenz A., Mannel D.N., Ortmann O., Kroemer A., Brockhoff G. Humanized tumor mice-A new model to study and manipulate the immune response in advanced cancer therapy. Int. J. Cancer 2011, 129:2194-2206.
228. Wege A.K., Schmidt M., Ueberham E., Ponnath M., Ortmann O., Brockhoff G., Lehmann J. Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies. MAbs 2014, 6:968-977.
229. Werner-Klein M., Proske J., Werno C., Schneider K., Hofmann H.S., Rack B., Buchholz S., Ganzer R., Blana A., Seelbach-Gobel B., Nitsche U., Mannel D.N., Klein C.A. Immune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patients. PLoS One 2014, 9:e97860.
230. Whaley K.J., Morton J., Hume S., Hiatt E., Bratcher B., Klimyuk V., Hiatt A., Pauly M., Zeitlin L. Emerging antibody-based products. Curr. Top. Microbiol. Immunol. 2014, 375:107-126.
231. Wheeler L.A., Vrbanac V., Trifonova R., Brehm M.A., Gilboa-Geffen A., Tanno S., Greiner D.L., Luster A.D., Tager A.M., Lieberman J. Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras. Mol. Ther. 2013, 21:1378-1389.
232. Whitfield-Larry F., Young E.F., Talmage G., Fudge E., Azam A., Patel S., Largay J., Byrd W., Buse J., Calikoglu A.S., Shultz L.D., Frelinger J.A. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/gammac(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells. Diabetes 2011, 60:1726-1733.
233. WHO World Malaria Report http://www.who.int/malaria/publications/world_malaria_report_2014/en/.
234. Wijayalath W., Majji S., Villasante E.F., Brumeanu T.D., Richie T.L., Casares S. Humanized HLA-DR4.RagKO.IL2RgammacKO.NOD (DRAG) mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria. Malar. J. 2014, 13:386.
235. Willinger T., Rongvaux A., Takizawa H., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Auerbach W., Eynon E.E., Stevens S., Manz M.G., Flavell R.A. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2390-2395.
236. Wilson E.M., Bial J., Tarlow B., Bial G., Jensen B., Greiner D.L., Brehm M.A., Grompe M. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014, 13:404-412.
237. Wolfe N.D., Dunavan C.P., Diamond J. Origins of major human infectious diseases. Nature 2007, 447:279-283.
238. Wong K.K., Brenneman F., Chesney A., Spaner D.E., Gorczynski R.M. Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice. Cancer Res. 2012, 72:4931-4943.
239. Wong G., Qiu X., Olinger G.G., Kobinger G.P. Post-exposure therapy of filovirus infections. Trends Microbiol. 2014, 22:456-463.
240. Yamauchi T., Takenaka K., Urata S., Shima T., Kikushige Y., Tokuyama T., Iwamoto C., Nishihara M., Iwasaki H., Miyamoto T., Honma N., Nakao M., Matozaki T., Akashi K. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood 2013, 121:1316-1325.
241. Ye C., Choi J.G., Abraham S., Wu H., Diaz D., Terreros D., Shankar P., Manjunath N. Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:21052-21057.
242. Yoshizato K., Tateno C. A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next?. Expert Opin. Drug Metab. Toxicol. 2013, 9:1419-1435.
243. Zadeh-Khorasani M., Nolte T., Mueller T.D., Pechlivanis M., Rueff F., Wollenberg A., Fricker G., Wolf E., Siebeck M., Gropp R. NOD-scid IL2R gammanull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways. J. Transl. Med. 2013, 11:4.
244. Zayoud M., El M.K., Frauenknecht K., Trinschek B., Kloos L., Karram K., Wanke F., Georgescu J., Hartwig U.F., Sommer C., Jonuleit H., Waisman A., Kurschus F.C. Subclinical CNS inflammation as response to a myelin antigen in humanized mice. J. Neuroimmune Pharmacol. 2013, 8:1037-1047.
245. Zhao Y., Moon E., Carpenito C., Paulos C.M., Liu X., Brennan A.L., Chew A., Carroll R.G., Scholler J., Levine B.L., Albelda S.M., June C.H. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res. 2010, 70:9053-9061.